...
首页> 外文期刊>Genes, Chromosomes and Cancer >Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis.
【24h】

Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis.

机译:使用微卫星和22号染色体平铺路径阵列分析确定的星形细胞肿瘤中复杂的22号染色体重排。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Many studies have reported chromosome 22 as being abnormal in astrocytic tumors. In an attempt to map precisely the abnormal region or regions that potentially harbor tumor-suppressor genes or oncogenes, we constructed a chromosome 22 tile path array covering 82% of 22q with the use of 441 chromosome 22 clones. A 10-Mb whole-genome array consisting of 270 clones from all autosomes was included in the array. A total of 126 astrocytic tumors-5 diffuse astrocytomas (A), 29 anaplastic astrocytomas (AA), and 92 glioblastomas (GB)-were examined for chromosome 22 alterations both by microsatellite analysis (using 28 markers to identify allelic imbalance) and with the tile path array. The results showed that chromosome 22 alterations in astrocytic tumors could be complex. A number of tumors had a combination of deletions with and without reduplication of the retained chromosome, as well as copy number gains and amplifications. In two glioblastomas, overlapping homozygous deletions were identified that involvedthree genes (DEPDC5/KIAA0645, YWHAH, C22ORF24/HSN44A4A). The terminal region telomeric to the clone RP3-398C22 appeared to be the most frequently deleted region. The estimated incidence of any chromosome 22 alteration was 5% in A, 33% in AA, and 38% in GB. This study demonstrated the advantages of combining array comparative genomic hybridization and microsatellite analysis in elucidating complex genomic rearrangements in primary human tumor tissue. Supplementary material for this article can be found on the Genes, Chromosomes and Cancer website at http://www.interscience.wiley.com/jpages/1045-2257/suppmat/index.html.
机译:许多研究报告染色体22在星形细胞肿瘤中异常。为了精确定位可能包含肿瘤抑制基因或癌基因的异常区域,我们使用441号22号染色体克隆构建了22号染色体图块路径阵列,覆盖了22q的82%。 10 Mb全基因组阵列包括来自所有常染色体的270个克隆。通过微卫星分析(使用28个标记物识别等位基因失衡)和通过共检查了126个星形细胞肿瘤,5个弥漫性星形细胞瘤(A),29个间变性星形细胞瘤(AA)和92个胶质母细胞瘤(GB)。平铺路径数组。结果表明,星形细胞肿瘤中的22号染色体改变可能很复杂。许多肿瘤具有缺失和保留染色体的不重复的组合,以及拷贝数的增加和扩增。在两个胶质母细胞瘤中,鉴定出涉及三个基因的重叠纯合缺失(DEPDC5 / KIAA0645,YWHAH,C22ORF24 / HSN44A4A)。克隆RP3-398C22的端粒末端区域似乎是最常缺失的区域。任何22号染色体改变的估计发生率在A中为5%,在AA中为33%,在GB中为38%。这项研究证明了结合阵列比较基因组杂交和微卫星分析在阐明人类原发性肿瘤组织中复杂的基因组重排中的优势。可以在基因,染色体和癌症网站上找到本文的补充材料,网址为http://www.interscience.wiley.com/jpages/1045-2257/suppmat/index.html。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号